N-Substituted amides of endo -3-(3-methylthio-1,2,4-triazol-5-yl)
Introduction
During recent years an increasing number of cases of bacterial diseases caused by strains resistant to antimicrobials, e.g. antibiotics, has been noted (Sriram et al., 2005; Narain et al., 2002; Sbarbaro, 1997) . One of the most important points in modern medicine is to pay attention to the progress in novel approaches to antimicrobial therapy (Capobianco et al., 2000; Chopra, 2001; Choudhry et al., 2003; Oliva et al., 2003) .
Five-membered heterocyclic compounds containing nitrogen, especially 1,2,4-triazole and its derivatives, are highly prevalent in collections of bioactive compounds. It is well-known that they can be applied as anti-infl ammatory (Amir and Shikha, 2004) , antidepressant (Chiu and Huskey, 1998) , antiviral (Al-Soud et al., 2004 ), anticonvulsant (Almasirad et al., 2004 , analgesic (Kumar et al., 2008) , and anticancer (Demirbas and Ugurluoglu, 2002) agents, respectively. Moreover, some of them possess antifungal (Turan-Zitouni et al., 2005) , antimicrobial (Demirbas et al., 2005) , and antitubercular (Walczak et al., 2004) properties. Besides, a literature survey reveals that the 1,2,4-triazole system is the structural nucleus of vorozole, letrazole, and anastrozole (Clemons et al., 2004; Goss and Strasser-Weippl, 2004; Santen, 2003) which are very effective nonsteroidal aromatase inhibitors. Virazole (Shigeta, 2000) is an antiviral agent. Alprazolam (De Witte et al., 2002) is used as an anxiolytic agent, nefazodone (Spina et al., 2008) and trazodone (Kast, 2009) are antidepressant drugs, fl uconazole (Tsukuda at al., 1998) and intraconazole (Bailey et al., 1990) are used as antifungal drugs. Therefore triazoles are potential scaffolds for the design of bioactive compounds.
Prompted by these reports, and in continuation of our search for bioactive molecules (Pitucha et al., , 2010 , it seemed worthwhile to synthesize derivatives of 1,2,4-triazole, containing the amide and methylthio group like compounds with potential biological activity (Pachuta-Stec et al., 2009) . The syntheses and molecular structures have been described earlier (Mendyk et al., 2011; Galewicz-Walesa and Pachuta-Stec, 2003) . Here we report the evaluation of the results of the preliminary microbiological investigation. Two of the synthesized compounds, 4a and 10a, were also examined with reference to their effect on the central nervous system (CNS) of mice. These compounds were chosen as prototypes for the ali- phatic and aromatic series of side chains. Moreover, triazoles with chlorophenyl and butyl substituents attached to the heterocyclic system had been shown to exhibit moderate to good CNS activity in mice (Amir et al., 2008; Kane et al., 1990; Karthikeyan, 2009; Tozkoparan et al., 2007) .
Results and Discussion
The starting endo-S-methyl-N 1 -(bicyclo[2.2.1]-hept-5-ene-2,3-dicarbonyl)isothiosemicarbazide and S-methyl-N 1 -(cyclohexane-2,3-dicarbonyl)-iso thi osemicarbazide, used in this study, were obtained by the direct condensation of S-methyl isothiosemicarbazide hydroiodide with a suitable dicarboxylic acid anhydride. The N-substituted amides were prepared by the condensation of the abovementioned isothiosemicarbazides with aliphatic and aromatic primary amines in boiling glacial acetic acid (Mendyk et al., 2011; GalewiczWalesa and Pachuta-Stec, 2003) . The chemical structures of the obtained and examined compounds are presented in Fig. 1 .
According to our preliminary results based on the agar well diffusion method, among the tested agents 1a -13a and 1b -12b, only compounds 1a, 7a, 7b, 9b, and 13a showed potential activity against Gram-positive or Gram-negative bacteria, as monitored by the growth inhibition zone around the well with the diameter ranging from 13 to 16 mm. On the basis of the MIC (minimal inhibitory concentration) values obtained by the broth microdilution method, it became clear that only few of these compounds had moderate ac- 
parapsilosis).
Preliminary pharmacological results have shown that compounds 4a and 10a do not display neurotoxic activity and weakly affect the mice CNS. Both compounds had analgesic activity in the writhing syndrome test (Table I) . Compound 10a, N-(2-chlorophenyl) amide of endo-3-(3-methylthio-1,2,4-triazol-5-yl)bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, was more active because in a wide range of doses it decreased the pain reactivity of mice in this test. The analgesic effect of 10a is interesting and should be further examined in more detail. In the other behavioural tests, the investigated N-substituted amides of endo-3-(3-methylthio-1,2,4-triazol-5-yl)bicyclo[2.2.1]hept-5-ene-2-carboxylic acid had basically no effect. The hole board test and the four plate test did not reveal any potential anxiolytic character of the tested compounds. The forced swimming test did not show antidepressant effects on the behaviour of mice. The investigated compounds did not prolong thiopental sleeping time and did not show any anticonvulsant effect. In the head twitch test, none of the compounds showed antiserotoninergic activity. Summing up, it was shown that compound 10a has analgesic activity which will be further investigated and tested on rodents.
Experimental

Microbiology
The new compounds 1a -13a and 1b -12b were screened for their antimicrobial activity in vitro against eight species of aerobic bacteria and six species of fungi. All these microorganisms came from the American Type Culture Collection (ATCC; Dziekanów Leśny, Poland) and are routinely used for evaluation of antimicrobials. The reference strains of aerobic bacteria included Microbial suspensions were prepared in sterile saline (0.85% NaCl) with an optical density of 0.5 McFarland standard, 150 · 10 6 CFU (colony forming units)/mL. All stock solutions of the tested compounds were dissolved in dimethyl sulfoxide (DMSO). It was found that DMSO at the fi nal concentration employed did not affect the growth of the tested microorganisms.
Antimicrobial activities of the newly synthesized compounds were screened by the agar well diffusion method and, for potentially active ones, by the broth microdilution technique. Using the agar well diffusion method, the antimicrobial activity of the tested agents was expressed as the average diameter of the growth inhibition zone surrounding the well containing the compounds at a concentration of 1000 μg/mL. Mueller-Hinton agar or Mueller-Hinton agar supplemented with 2% glucose were used. Sterile swabs were used to spread the microbial suspensions onto the medium surface, and then the solution of each compound was introduced into the wells (80 μL per each well). The wells (d = 8 mm) were made in the agar with a sterile cork-borer. The plates were preincubated at room temperature for 1.5 h to allow the diffusion of solution into the medium, and then they were incubated at 37 °C for 18 h (for bacteria) or at 30 °C for 48 h (for fungi).
Further experiments were focused on the assessment of the activity of compounds 1a, 7a, 7b, 9b, 11a, and 13a allowing for MIC determination using the broth microdilution method (OD 600 ). Mueller-Hinton broth (for bacteria) or Mueller-Hinton broth with 2% glucose (for fungi) containing compounds at concentrations of 31.25 -500 μg/mL were used. This technique was developed using 96-well microplates which were inoculated with an 1:10 diluted microbial suspension of an optical density of 0.5 McFarland standard; 20 μL of bacterial suspension were transferred into 180 μL of medium containing a two-fold dilution of the tested compounds. After incubation (at 37 °C for 18 h for bacteria and at 30 °C for 24 h for fungi), the optical densities (OD 600 ) were determined for bacterial cultures in the broth medium and the MIC values were determined by comparison with the growth of the control (compound-free) medium. Cefuroxime, belonging to the 2 nd generation of cephalosporins, was used as a control antimicrobial agent at fi nal concentrations of 0.063 to 500 μg/mL.
Pharmacological studies
The experiments were carried out on male Albino Swiss mice (20 -24 g). The animals were kept in colony cages with free access to food (standard laboratory pellets; Bacutil Motycz, Poland) and tap water, and maintained in the natural light-dark cycle. The experiments were performed between 8 a.m. and 2 p.m. The investigated compounds 4a and 10a were administered intraperitoneally (i.p.) in doses of 12.5, 25, 50, and 100 mg/kg body, respectively, as suspensions in 1% aqueous Tween 80 solution at a constant volume of 0.1 mL per 10 g body weight of mice. Control animals received an equivalent volume of the solvent. The tested groups consisted of 8 mice. The Bioethical Committee of Lublin Medical University had approved all experimental procedures applied in this study.
Screening of the CNS activity in mice was performed in a series of tests described below. Motor coordination was quantifi ed with the chimney test (Boissier et al., 1960) . The rectal body temperature in mice was measured by an Ellab thermometer. The effects on the explorative activity were determined applying the hole board test (Boissier and Simon, 1967) . Anxiolytic activity was assessed by the four plate test in mice according to Aron et al. (1971) . The passive avoidance task, which is considered to be a measure of long-term memory in rodents, followed the procedure of Venault et al. (1986) . Antidepressant properties were assessed by the forced swimming test (Porsolt et al., 1977) . Thiopental-induced sleep was measured too. Analgesic activity was measured by the writhing syndrome test (Witkin et al., 1961) . Antiepileptic effects were tested by reduction of pentetrazole (100 mg/kg body weight)-induced seizures. Antiserotoninergic effects were determined by the Corne test (Corne et al., 1963) . 
